Pacific Pharma faces suspension or delisting for non-compliance

Published: 2012-06-04 06:56:00
Updated: 2012-06-04 06:56:00
Korea Exchange, the country’s bourse operator, announced on Thursday it may suspend the trading of Pacific Pharma shares from July 1 due to their non-compliance to the Listing Act clauses.

KRX said that from the company’s 2,328,947 floating shares, 95,903 shares only had been traded during the...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.